COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

30,900 Articles (22,568 medRxiv, 8,332 bioRxiv)

Most recent first Previous |  Page 459: Articles 4581-4590  | Next

A Bayesian inference method to estimate transmission trees with multiple introductions; applied to SARS-CoV-2 in Dutch mink farms.
Van der Roest, B. R., Bootsma, M., Fischer, E., Klinkenberg, D., Kretzschmar, M.
10.1101/2023.02.07.527429 — Posted: 2023-02-07
Dogs and cats are less susceptible to the omicron variant of concern of SARS-CoV-2 - a field study
Klein, C., Michelitsch, A., Allendorf, V., Conraths, F. J., Beer, M., Denzin, N., Wernike, K.
10.1101/2023.02.07.527419 — Posted: 2023-02-07
Serosurvey of SARS-COV-2 at a large public university
Hou, C.-W., Williams, S., Taylor, K., Boyle, V., Bobbett, B., Kouvetakis, J., Nguyen, K., McDonald, A., Harris, V., Nussle, B., Scharf, P., Jehn, M., Lant, T., Magee, M., Chung, Y., Labaer, J., Murugan, V.
10.1101/2023.02.05.23285494 — Posted: 2023-02-07
Predicting COVID-19 case status from self-reported symptoms and behaviors using data from a massive online survey
Srivastava, M., Reinhart, A., Mejia, R.
10.1101/2023.02.03.23285405 — Posted: 2023-02-07
Understanding the Impact of Social Engagement Activities, Health Protocol Maintenance, and Social Interaction on Depression During Covid-19 Pandemic Among Older Americans
Ahmmad, R.
10.1101/2023.02.04.23285479 — Posted: 2023-02-07
Addressing a climate emergency amidst the COVID-19 pandemic: A mixed-methods study on a hospital evacuation during the 2021 European floods
van der Wal, W., Barten, D., Ketelings, L., van Osch, F., Rao, M., Mortelmans, L., Bierens, J.
10.1101/2023.02.02.23285386 — Posted: 2023-02-07
Impact of Immune Evasion, Waning and Boosting on Dynamics ofPopulation Mixing Between a Vaccinated Majority and Unvaccinated Minority
Fisman, D., Amoako, A., Simmons, A., Tuite, A.
10.1101/2023.02.03.23285437 — Posted: 2023-02-07
Olfactory Dysfunction in the COVID-19 Era: An Umbrella Review Focused on Neuroimaging, Management, and Follow-up
Kalantarhormozi, M., Sotoudeh, H., Habibi, M. A., Mahmudpour, M., Shahidi, R., Khalaj, F., Karami, S., Asgarzadeh, A., Baradaran, M., Chichagi, F., Hassanzadeh, S., Farizani Gohari, N. S., Shirforoush Sattari, M., Azimi, A., Dadjou, A., Eskandari, M.
10.1101/2023.02.07.23285588 — Posted: 2023-02-07
Underlying driving forces of the SARS-CoV-2 evolution: immune evasion and ACE2 binding affinity
Ma, W., Fu, H., Jian, F., Cao, Y., Li, M.
10.1101/2023.02.06.527236 — Posted: 2023-02-07
A COVID-19 DNA Vaccine Candidate Elicits Broadly Neutralizing Antibodies Against Multiple SARS-CoV-2 Variants Including the Currently Circulating Omicron BF.5, BF.7, BQ.1 and XBB
Ding, Y., Fan, F., Xu, X., Zhao, G., Zhang, X., Zhao, H., Wang, L., Wang, B., Gao, X.-M.
10.1101/2023.02.06.527382 — Posted: 2023-02-07

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).